ATE149567T1 - Menschliche zytosolische phospholipase a2 - Google Patents

Menschliche zytosolische phospholipase a2

Info

Publication number
ATE149567T1
ATE149567T1 AT91307746T AT91307746T ATE149567T1 AT E149567 T1 ATE149567 T1 AT E149567T1 AT 91307746 T AT91307746 T AT 91307746T AT 91307746 T AT91307746 T AT 91307746T AT E149567 T1 ATE149567 T1 AT E149567T1
Authority
AT
Austria
Prior art keywords
novel
cytosolic phospholipase
human cytosolic
pla2
phospholipase
Prior art date
Application number
AT91307746T
Other languages
English (en)
Inventor
Ruth Maria Kramer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE149567T1 publication Critical patent/ATE149567T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/918—Carboxylic ester hydrolases (3.1.1)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Detergent Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT91307746T 1990-08-24 1991-08-22 Menschliche zytosolische phospholipase a2 ATE149567T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57351390A 1990-08-24 1990-08-24

Publications (1)

Publication Number Publication Date
ATE149567T1 true ATE149567T1 (de) 1997-03-15

Family

ID=24292288

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91307746T ATE149567T1 (de) 1990-08-24 1991-08-22 Menschliche zytosolische phospholipase a2

Country Status (12)

Country Link
EP (1) EP0476849B1 (de)
JP (1) JPH0829080B2 (de)
AT (1) ATE149567T1 (de)
AU (1) AU643061B2 (de)
CA (1) CA2049482A1 (de)
DE (1) DE69124893T2 (de)
DK (1) DK0476849T3 (de)
ES (1) ES2098326T3 (de)
GR (1) GR3023061T3 (de)
HU (1) HUT61588A (de)
IE (1) IE912994A1 (de)
IL (1) IL99227A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453443A (en) * 1994-07-20 1995-09-26 Merck Frosst Canada, Inc. Bis(aryloxy)alkanes as inhibitors of phospholipase A2 enzymes
CA2365973A1 (en) 1999-03-09 2000-09-14 Laxdale Limited Diagnostic test
KR20040001144A (ko) * 2002-06-27 2004-01-07 김대경 신규한 적혈구 세포질형 포스포리파아제 에이 투 효소,그에 대한 항체, 이들의 용도 및 제조 방법
WO2004081230A1 (ja) * 2003-03-13 2004-09-23 Nippon Soda Co. Ltd. 生理的な活性型構造機能を反映する機能因子の活性評価方法およびその使用
CN103338636A (zh) * 2010-12-07 2013-10-02 好时公司 影响脂肪酸摄取和代谢及炎性介质产生的化合物和从可可产品中分离所述化合物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6443193A (en) * 1987-08-11 1989-02-15 Tanpaku Kogaku Kenkyusho Kk Production of phospholipase a2
JPH03503843A (ja) * 1988-04-15 1991-08-29 バイオジェン インコーポレイテッド ホスホリパーゼａ２の精製方法およびホスホリパーゼａ２様ポリペプチドの製造方法
IL101507A0 (en) * 1991-04-17 1992-12-30 Lilly Co Eli Compounds,vectors and methods for expressing human,cytosolic phospholipase a2

Also Published As

Publication number Publication date
JPH0829080B2 (ja) 1996-03-27
EP0476849B1 (de) 1997-03-05
IE912994A1 (en) 1992-02-26
IL99227A (en) 1996-10-16
AU8269891A (en) 1993-04-08
JPH0591874A (ja) 1993-04-16
DK0476849T3 (da) 1997-07-28
DE69124893D1 (de) 1997-04-10
HU912779D0 (en) 1992-01-28
CA2049482A1 (en) 1992-02-25
DE69124893T2 (de) 1997-09-11
EP0476849A2 (de) 1992-03-25
HUT61588A (en) 1993-01-28
ES2098326T3 (es) 1997-05-01
AU643061B2 (en) 1993-11-04
EP0476849A3 (en) 1992-06-17
IL99227A0 (en) 1992-07-15
GR3023061T3 (en) 1997-07-30

Similar Documents

Publication Publication Date Title
DK1188768T3 (da) LHRH-antagonisk-peptider
BR9408087A (pt) Recuperação de um aminoácido
NO885013D0 (no) FremgangsmŸte for fremstilling av bionedbrytbare mikrokapsler av vannopplelige peptider og proteiner, samt mikroka psler oppnŸdd ved fremgangsmŸten.
NZ301290A (en) Mycobacterial proteins, micro-organisms producing same and vaccines thereof
RU1833372C (ru) Cпocoб пoлучehия пpoизboдhыx 2,4,5-зameщehhыx бehзoлa
EP1452540A3 (de) Molekularsequenz von Schweineretrovirus sowie Anwendungsverfahren
ES2127181T3 (es) 11-beta-aril-gona-4,9-dien-3-onas.
FI945354A7 (fi) Sykliset aminohappojohdannaiset
DE69124893D1 (de) Menschliche Zytosolische Phospholipase A2
AU1634388A (en) Cyclic anticoagulant peptides
DK627687A (da) Hirudinvariant
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
EA199800102A1 (ru) Получение производных бициклогексана
ATE41773T1 (de) 4,5-dihydro-4-oxo-2((2-transphenylcyclopropyl)amino>-3-furancarbonsaeuren und derivate davon.
DE69127303D1 (de) Substituierte Triazolopyridazine
DK0403458T3 (da) Hidtil ukendte polypeptider og anvendelse deraf
FR2713785B1 (fr) Système de repérage d'orientation d'un instrument d'observation.
DK166343C (da) Forbedret piroxicamholdigt laegemiddel
NO903338L (no) Fremgangsmaate for mikrobiologisk fremstilling av l-carnitin.
ES2157614T3 (es) Procedimiento para la preparacion de diacil-imidas.
EA199600048A2 (ru) N,n-диэтил-8,8-дипропил-2-азаспиро[4,5]декан-2-пропанамин дималеат, фармацевтическая композиция на его основе и способ индуцирования иммуномодуляции
DK0468063T3 (da) En-beholder fremgangsmåde til fremstilling af -L-asparatyl-L-phenylalanin-methylester, hydrochlorid
BR9712805A (pt) Processo para a preparação de compostos farmecêuticos
BR9611341A (pt) Preparação de aril e vinil nitrilas
ATE170292T1 (de) Nachweis von antibiotika

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee